Beverly, MA and Bethesda, MD – BIOBASE, a leading provider of biological databases and software for the life sciences industry, announced today the renewal of the second year of a 5-year licensing agreement with the National Institutes of Health (NIH). This 5-year contract provides all 27 NIH institutions with locally installed access to the BIOBASE Knowledge Library™ which includes the premier TRANSFAC® and PROTEOME® databases. In addition, NIH researchers have access to the ExPlain™ Analysis System, a software platform that facilitates the analysis and biological interpretation of large-scale data sets generated by DNA microarrays, as well as proteomics, ChIP-on-chip and Chip-Seq experiments. “We are very pleased that such a highly respected institution has acknowledged the value in our products through this renewal, and are confident NIH researchers will

continue to benefit from the use of our databases and software over the years” states Prof. Dr. Edgar Wingender, President and CSO of BIOBASE.

Financial terms and conditions of the agreement were not disclosed.

About BIOBASE

BIOBASE (www.biobase-international.com), based in Wolfenbüttel (Germany), with branch offices in Beverly, MA (USA), Bangalore (India) and Yokohama (Japan), is a leading provider of expertly curated biological databases for the life science industry. BIOBASE’s product portfolio, referred to as the BIOBASE Knowledge Library (BKL), includes industry standards such as TRANSFAC®, RANSPATH®, PROTEOME YPDÔ and HumanPSD™ databases. In combination with BIOBASE’s powerful systems biology tool, ExPlain, the BKL can be used to analyze complex regulatory networks and identify key molecules linked to human disease. In addition to the BKL, BIOBASE provides a growing collection of third-party databases including BRENDA and the Human Gene Mutation Database (HGMD). More than 600 customers now license BIOBASE databases worldwide.

About NIH

The National Institutes of Health (www.nih.gov) — The Nation’s Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.